TMCnet News
Adverum to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceMENLO PARK, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the company will be participating in the upcoming 8th Annual SVB Leerink Global Healthcare Conference in New York, NY. Adverum’s management is scheduled to present on Wednesday, February 27, 2019 at 3:30pm Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.adverum.com. The webcast wil be available on the company’s website for at least two weeks following the event. About Adverum Biotechnologies, Inc. Investor and Media Inquiries: Katherine Bock Vice President Investor Relations & Corporate Communications Adverum Biotechnologies, Inc. 650-656-9347 [email protected] |